Next Article in Journal
Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period
Next Article in Special Issue
Decoding iNOS Inhibition: A Computational Voyage of Tavaborole Toward Restoring Endothelial Homeostasis in Venous Leg Ulcers
Previous Article in Journal
Unraveling Cannabidiol’s Bidirectional Regulation of Melatonin Pharmacokinetics via PEPT1/CYP1A2: Mechanistic Insights and Quantitative Projections
Previous Article in Special Issue
Advances in Near-Infrared BODIPY Photosensitizers: Design Strategies and Applications in Photodynamic and Photothermal Therapy
 
 
Review

Article Versions Notes

Pharmaceuticals 2026, 19(1), 81; https://doi.org/10.3390/ph19010081
Action Date Notes Link
article html file updated 4 January 2026 02:28 CET Update https://www.mdpi.com/1424-8247/19/1/81/html
article pdf uploaded. 4 January 2026 02:25 CET Updated version of record https://www.mdpi.com/1424-8247/19/1/81/pdf
article xml uploaded. 4 January 2026 02:25 CET Update https://www.mdpi.com/1424-8247/19/1/81/xml
article xml file uploaded 4 January 2026 02:25 CET Update -
article html file updated 31 December 2025 08:47 CET Original file -
article pdf uploaded. 31 December 2025 08:42 CET Updated version of record https://www.mdpi.com/1424-8247/19/1/81/pdf-vor
article xml uploaded. 31 December 2025 08:42 CET Update -
article xml file uploaded 31 December 2025 08:42 CET Original file -
article pdf uploaded. 30 December 2025 17:09 CET Version of Record https://www.mdpi.com/1424-8247/19/1/81/pdf-vor
Back to TopTop